TY - JOUR
T1 - Characteristics of Proinflammatory Cytokines and Chemokines in Airways of Asthmatics
T2 - Relationships with Disease Severity and Infiltration of Inflammatory Cells
AU - Yang, Ting
AU - Li, Yan
AU - Lyu, Zhe
AU - Huang, Kewu
AU - Corrigan, Christopher J
AU - Ying, Sun
AU - Wang, Wei
AU - Wang, Chen
PY - 2017/9/5
Y1 - 2017/9/5
N2 - Background: Increased proinflammatory cytokines and chemokines might contribute to infiltration of inflammatory cells and remodelingin airways of asthma. Although these molecules may be associated with asthma, there is lack of systemic evidence showing which andhow important these events are in the disease. We aimed to analyze the concentrations of these molecules in the airways and relationshipswith disease severity and with airway infiltration of inflammatory cells in a large cohort of asthmatics (n = 70, including 37 mild and33 moderate/severe asthmatics) compared with controls (n = 30).Methods: Meso scale discovery system and commercial ELISA kits were used to measure the concentrations of proinflammatory cytokinesinterleukin (IL)‑1β; tumor necrosis factor‑alpha (TNF‑α); IL‑6; and IL‑17 and CC and CXC chemokines CCL2, CCL4, CCL11, CCL13,CCL17, CCL22, and CCL26 and CXCL8, CXCL9, CXCL10, and CXCL11 in bronchoalveolar lavage fluid of asthmatics and controls.Results: The concentrations of IL‑1, TNF‑α, IL‑6, CXCL8 and CXCL10, and CCL4, CCL11, CCL17, and CCL22 were significantly elevatedin asthmatics compared with controls (P < 0.05). The concentrations of TNF‑α and CXCL8, but not others, were negatively correlated withseverity of disease (lung function forced expiratory volume in 1 s) (TNF‑α vs. total: r = −0.359, P = 0.002 vs. moderate/severe: r = −0.541,P = 0.001; CXCL8 vs. total: r = −0.327, P = 0.006 vs. moderate/severe: r = −0.625, P = 0.0001, respectively). In addition, concentrationsof these two molecules were also correlated with the absolute numbers of infiltrating eosinophils and neutrophils in asthmatic airways.Conclusions: Increased concentrations of TNF‑α and CXCL8 are associated with pathogenesis of asthma. Targeting these moleculesmight provide an alternative therapeutic for this disease.
AB - Background: Increased proinflammatory cytokines and chemokines might contribute to infiltration of inflammatory cells and remodelingin airways of asthma. Although these molecules may be associated with asthma, there is lack of systemic evidence showing which andhow important these events are in the disease. We aimed to analyze the concentrations of these molecules in the airways and relationshipswith disease severity and with airway infiltration of inflammatory cells in a large cohort of asthmatics (n = 70, including 37 mild and33 moderate/severe asthmatics) compared with controls (n = 30).Methods: Meso scale discovery system and commercial ELISA kits were used to measure the concentrations of proinflammatory cytokinesinterleukin (IL)‑1β; tumor necrosis factor‑alpha (TNF‑α); IL‑6; and IL‑17 and CC and CXC chemokines CCL2, CCL4, CCL11, CCL13,CCL17, CCL22, and CCL26 and CXCL8, CXCL9, CXCL10, and CXCL11 in bronchoalveolar lavage fluid of asthmatics and controls.Results: The concentrations of IL‑1, TNF‑α, IL‑6, CXCL8 and CXCL10, and CCL4, CCL11, CCL17, and CCL22 were significantly elevatedin asthmatics compared with controls (P < 0.05). The concentrations of TNF‑α and CXCL8, but not others, were negatively correlated withseverity of disease (lung function forced expiratory volume in 1 s) (TNF‑α vs. total: r = −0.359, P = 0.002 vs. moderate/severe: r = −0.541,P = 0.001; CXCL8 vs. total: r = −0.327, P = 0.006 vs. moderate/severe: r = −0.625, P = 0.0001, respectively). In addition, concentrationsof these two molecules were also correlated with the absolute numbers of infiltrating eosinophils and neutrophils in asthmatic airways.Conclusions: Increased concentrations of TNF‑α and CXCL8 are associated with pathogenesis of asthma. Targeting these moleculesmight provide an alternative therapeutic for this disease.
KW - Asthma
KW - Proinflammatory Cytokines
KW - Chemokine
KW - Bronchoalveolar Lavage
U2 - 10.4103/0366-6999.213428
DO - 10.4103/0366-6999.213428
M3 - Article
SN - 0366-6999
VL - 130
SP - 2033
EP - 2040
JO - Chinese Medical Journal
JF - Chinese Medical Journal
IS - 17
ER -